Co-Authors
This is a "connection" page, showing publications co-authored by MICHAEL ANDREEFF and GORDON B MILLS.
Connection Strength
0.291
-
Functional proteomic profiling of AML predicts response and survival. Blood. 2009 Jan 01; 113(1):154-64.
Score: 0.081
-
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias. Leukemia. 2004 Feb; 18(2):267-75.
Score: 0.059
-
Targeted therapy of AML new concepts. Ann Hematol. 2004; 83 Suppl 1:S51-3.
Score: 0.059
-
Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML. Blood. 2012 Jul 05; 120(1):173-80.
Score: 0.026
-
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res. 2007 Jan 15; 67(2):684-94.
Score: 0.018
-
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol Cancer Ther. 2006 Oct; 5(10):2512-21.
Score: 0.018
-
Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia. Cancer Res. 2006 Apr 01; 66(7):3737-46.
Score: 0.017
-
Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Mol Cancer Ther. 2002 Oct; 1(12):989-97.
Score: 0.013